Company: INMB
Filing Date: 2025-06-26
Form Type: 8-K
Source: 0001213900-25-058380
Chunk: 0

Company: Inmune Bio, Inc.
Filing Date: 2025-06-26
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01. Other Events.

On
June 26, 2025, INmune Bio Inc. issued a press release announcing it will host a conference call on Monday, June 30, 2025, at 8:00 a. m.,
Eastern Time to present top line data from the Phase 2 MINDFuL trial in early Alzheimer’s disease. A copy of the press release is
attached herewith as Exhibit 99.1.

Item 9.01 Financial statements and Exhibits